Ariella B Hanker

15PUBLICATIONS
150CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMetabolic medicineTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 29, 2026
Shaping CDK4/6 Inhibitor Resistance: BRCA2 Germline Alterations Bias toward RB1 Inactivation.

|Feb 24, 2025
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.

Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni

|Sep 03, 2024
Mapping cellular interactions from spatially resolved transcriptomics data.

James Zhu, Yunguan Wang, Woo Yong Chang

|Apr 09, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer.

Yaru Xu, Yuqiu Yang, Zhaoning Wang

|Mar 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.

Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang

|Jan 08, 2024
AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer.

Mauricio Marquez-Palencia, Luis Reza Herrera, Pravat Kumar Parida

Pageof 3

Frequent Collaborators

9 joint publications

Carlos L Arteaga

6 joint publications

Paula I Gonzalez-Ericsson

4 joint publications

Kyung-Min Lee

4 joint publications

Fabiana Napolitano